MDGS
Income statement / Annual
Last year (2023), Medigus Ltd.'s total revenue was $91.72 M,
a decrease of 0.15% from the previous year.
In 2023, Medigus Ltd.'s net income was -$16.03 M.
See Medigus Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$91.72 M
|
$91.86 M
|
$10.12 M
|
$531,000.00
|
$273,000.00
|
$436,000.00
|
$467,000.00
|
$549,000.00
|
$618,906.00
|
$684,141.00
|
| Cost of Revenue |
$79.88 M |
$77.41 M |
$5.32 M |
$1.03 M |
$455,000.00 |
$607,000.00 |
$516,000.00 |
$176,000.00 |
$274,870.00 |
$321,526.00 |
| Gross Profit |
$11.84 M |
$14.45 M |
$4.80 M |
-$503,000.00 |
-$182,000.00 |
-$171,000.00 |
-$49,000.00 |
$373,000.00 |
$344,036.00 |
$362,615.00 |
| Gross Profit Ratio |
0.13 |
0.16 |
0.47 |
-0.95 |
-0.67 |
-0.39 |
-0.1 |
0.68 |
0.56 |
0.53 |
| Research and Development
Expenses |
$5.89 M
|
$4.85 M
|
$1.05 M
|
$997,000.00
|
$609,000.00
|
$1.81 M
|
$2.21 M
|
$3.66 M
|
$4.36 M
|
$3.70 M
|
| General & Administrative
Expenses |
$12.11 M
|
$14.17 M
|
$9.96 M
|
$5.49 M
|
$13.18 M
|
$3.34 M
|
$3.01 M
|
$3.68 M
|
$2.83 M
|
$2.11 M
|
| Selling & Marketing
Expenses |
$4.66 M
|
$4.01 M
|
$1.99 M
|
$471,000.00
|
$326,000.00
|
$1.35 M
|
$846,000.00
|
$2.13 M
|
$2.66 M
|
$2.15 M
|
| Selling, General &
Administrative Expenses |
$16.77 M
|
$18.18 M
|
$11.95 M
|
$5.97 M
|
$13.51 M
|
$4.69 M
|
$3.85 M
|
$5.81 M
|
$5.49 M
|
$4.25 M
|
| Other Expenses |
$329,000.00 |
$45,000.00 |
$494,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$0.00 |
$0.00 |
| Operating Expenses |
$22.66 M |
$23.03 M |
$13.00 M |
$6.96 M |
$14.11 M |
$6.50 M |
$6.06 M |
$9.46 M |
$9.85 M |
$7.95 M |
| Cost And Expenses |
$102.54 M |
$100.44 M |
$18.31 M |
$8.00 M |
$14.57 M |
$7.11 M |
$6.58 M |
$9.64 M |
$10.12 M |
$8.27 M |
| Interest Income |
$0.00 |
$2.31 M |
$347,000.00 |
$205,000.00 |
$99,000.00 |
$0.00 |
$71,000.00 |
$99,000.00 |
$0.00 |
$30,817.00 |
| Interest Expense |
$1.53 M |
-$4.08 M |
$347,000.00 |
$0.00 |
$0.00 |
$0.00 |
$17,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3.98 M
|
$1.80 M
|
-$14.03 M
|
-$503,000.00
|
-$35,000.00
|
$42,000.00
|
$77,000.00
|
$99,000.00
|
$121,168.00
|
$75,502.00
|
| EBITDA |
-$12.84 M
|
-$11.99 M
|
-$22.23 M
|
-$7.89 M
|
-$14.46 M
|
-$6.78 M
|
-$5.96 M
|
-$9.02 M
|
-$9.49 M
|
-$8.68 M
|
| EBITDA Ratio |
-0.14 |
-0.13 |
-2.2 |
-14.85 |
-52.95 |
-15.55 |
-12.76 |
-16.42 |
-15.33 |
-12.69 |
| Operating Income Ratio
|
-0.25
|
-0.15
|
-0.81
|
-13.91
|
-52.82
|
-15.3
|
-13.08
|
-16.56
|
-15.35
|
-10.74
|
| Total Other
Income/Expenses Net |
$1.52 M
|
-$1.52 M
|
$12.35 M
|
$624,000.00
|
-$9.98 M
|
$94,000.00
|
$3.56 M
|
$112,000.00
|
$88,378.00
|
$992,562.00
|
| Income Before Tax |
-$21.81 M |
-$10.10 M |
$4.15 M |
-$6.84 M |
-$14.18 M |
-$6.58 M |
-$2.55 M |
-$8.98 M |
-$9.41 M |
-$5.81 M |
| Income Before Tax Ratio
|
-0.24
|
-0.11
|
0.41
|
-12.88
|
-51.94
|
-15.09
|
-5.46
|
-16.36
|
-15.21
|
-8.49
|
| Income Tax Expense |
-$74,000.00 |
$111,000.00 |
$105,000.00 |
$9,000.00 |
-$1,000.00 |
$20,000.00 |
-$7,000.00 |
$28,000.00 |
$67,628.00 |
$3,338.53 |
| Net Income |
-$16.03 M |
-$10.21 M |
$4.05 M |
-$6.85 M |
-$14.18 M |
-$6.60 M |
-$2.55 M |
-$9.01 M |
-$9.48 M |
-$5.81 M |
| Net Income Ratio |
-0.17 |
-0.11 |
0.4 |
-12.9 |
-51.93 |
-15.13 |
-5.45 |
-16.41 |
-15.32 |
-8.49 |
| EPS |
-9.5 |
-6.28 |
0.13 |
-0.77 |
-2.72 |
-48 |
-60.74 |
-785.47 |
0 |
0 |
| EPS Diluted |
-9.5 |
-6.28 |
0.13 |
-0.77 |
-2.72 |
-47.14 |
-69.88 |
-786 |
0 |
0 |
| Weighted Average Shares
Out |
$1.69 M
|
$1.63 M
|
$30.71 M
|
$8.90 M
|
$5.21 M
|
$137,458.00
|
$36,418.00
|
$11,459.00
|
$0.00
|
$0.00
|
| Weighted Average Shares
Out Diluted |
$1.69 M
|
$1.63 M
|
$30.71 M
|
$8.90 M
|
$5.21 M
|
$139,960.00
|
$43,230.00
|
$11,467.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
